An update on plant derived anti-androgens.

Authors:
Paul Grant
Paul Grant
Royal Sussex County Hospital
United Kingdom

Int J Endocrinol Metab 2012 20;10(2):497-502. Epub 2012 Apr 20.

Department of Endocrinology, Kings College Hospital, Denmark Hill, London, UK.

Anti-androgens are an assorted group of drugs and compounds that reduce the levels or activity of androgen hormones within the human body. Disease states in which this is relevant include polycystic ovarian syndrome, hirsutism, acne, benign prostatic hyperplasia, and endocrine related cancers such as carcinoma of the prostate. We provide an overview and discussion of the use of anti-androgen medications in clinical practice and explore the increasing recognition of the benefits of plant-derived anti-androgens, for example, spearmint tea in the management of PCOS, for which some evidence about efficacy is beginning to emerge. Other agents covered include red reishi, which has been shown to reduce levels 5-alpha reductase, the enzyme that facilitates conversion of testosterone to dihydrotestosterone (DHT); licorice, which has phytoestrogen effects and reduces testosterone levels; Chinese peony, which promotes the aromatization of testosterone into estrogen; green tea, which contains epigallocatechins and also inhibits 5-alpha reductase, thereby reducing the conversion of normal testosterone into the more potent DHT; black cohosh, which has been shown to kill both androgenresponsive and non-responsive human prostate cancer cells; chaste tree, which has a reduces prolactin from the anterior pituitary; and saw palmetto extract, which is used as an anti-androgen although it shown no difference in comparison to placebo in clinical trials.

Download full-text PDF

Source
http://dx.doi.org/10.5812/ijem.3644DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693613PMC
July 2013
39 Reads

Publication Analysis

Top Keywords

5-alpha reductase
8
reduce levels
8
conversion testosterone
4
testosterone dihydrotestosterone
4
dihydrotestosterone dht
4
testosterone
4
facilitates conversion
4
explore increasing
4
reductase enzyme
4
enzyme facilitates
4
dht licorice
4
licorice phytoestrogen
4
levels chinese
4
chinese peony
4
peony promotes
4
testosterone levels
4
reduces testosterone
4
phytoestrogen effects
4
effects reduces
4
levels 5-alpha
4

Similar Publications

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.

Endocr Pract 2015 Nov;21(11):1291-300

Polycystic Ovary Syndrome (PCOS) is recognized as the most common endocrine disorder of reproductive-aged women around the world. This document, produced by the collaboration of the American Association of Clinical Endocrinologists (AACE) and the Androgen Excess and PCOS Society (AES) aims to highlight the most important clinical issues confronting physicians and their patients with PCOS. It is a summary of current best practices in 2015. Read More

View Article
November 2015

Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.

Clin Endocrinol (Oxf) 1997 Feb;46(2):137-44

University Department of Surgery (WGH), Western General Hospital, Edinburgh, Scotland.

Objective: The 5 alpha-reductase inhibitor, finasteride, provides a logical medical treatment for benign prostatic hyperplasia (BPH). However, the effects of chronic finasteride treatment on prostatic androgen levels, 5 alpha-reductase activity and tissue prostatic specific antigen (PSA) have not been studied. We have examined prostate tissue androgen concentrations and 5 alpha-reductase activity of the gland in men with BPH treated with the drug for 3 months. Read More

View Article
February 1997

New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.

Biochimie 2013 Nov 9;95(11):2097-106. Epub 2013 Aug 9.

Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal; Institute for Molecular and Cell Biology (IBMC), University of Porto, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal.

The androgens testosterone (T) and dihydrotestosterone (DHT), besides playing an important role in prostate development and growth, are also responsible for the development and progression of benign prostate hyperplasia (BPH) and prostate cancer. Therefore, the actions of these hormones can be antagonized by preventing the irreversible conversion of T into DHT by inhibiting 5α-reductase (5α-R). This has been a useful therapeutic approach for the referred diseases and can be achieved by using 5α-reductase inhibitors (RIs). Read More

View Article
November 2013

Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.

Chin Med J (Engl) 2013 Feb;126(4):711-5

Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.

Background: 5α-Reductase inhibitors (5α-RI) act by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), thereby preventing DHT induced benign prostatic hyperplasia. The existing 5α-RIs can be classified into two types: competitive and noncompetitive. Currently, limited evidence is available concerning the effect differences between the two types of 5α-RI on androgens. Read More

View Article
February 2013